Mucopolysaccharidosis I under enzyme replacement therapy with laronidase - A mortality case with autopsy report

Journal of Inherited Metabolic Disease

Volumn 28, Issue 6, 2005, Pages 1146-1148

  Lin, H Y ^a   Lin, S P ^a,b   Chuang, C K ^a,c   Chen, M R ^a,b   Chen, B F ^a   Wraith, J E ^d  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^d ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LARONIDASE;

ADULT; ARTICLE; AUTOPSY; CASE REPORT; DETERIORATION; DNA DETERMINATION; ENZYME REPLACEMENT; GENE MUTATION; HEART FAILURE; HUMAN; HURLER SYNDROME; LUNG INFECTION; LUNG INSUFFICIENCY; MALE; OUTCOME ASSESSMENT; PATIENT REFERRAL; SCREENING TEST; TREATMENT DURATION;

ADULT; AUTOPSY; FATAL OUTCOME; GLYCOSAMINOGLYCANS; HEART FAILURE, CONGESTIVE; HEPARITIN SULFATE; HUMANS; IDURONIDASE; INFECTION; MALE; MUCOPOLYSACCHARIDOSIS I; PHARMACEUTICAL PREPARATIONS; RECOMBINANT PROTEINS;

EID: 31644436774     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-005-0211-x     Document Type: Article

References (10)

1. Chan YL, Lin SP, Man TT, et al (2001) Clinical experience in anesthetic management for children with mucopolysaccharidoses: Report of ten cases. Acta Paediatr Taiwan. 42: 306-308
2. Chen MR, Lin SP, Hwang HK, et al (2005) Cardiovascular changes in mucopolysaccharidoses in Taiwan. Acta Cardiol 60: 51-53.
3. Chuang CK, Lin SP, Chung SF (2001) Diagnostic screening for mucopolysaccharidoses by the dimethylmethylene blue method and two dimensional electrophoresis. Zhonghua Yi Xue Za Zhi (Taipei) 64:15-22.
4. Cunha DF, Cunha SF, Reis MA, et al (2002) Heart weight and heart weight/ body weight coefficient in malnourished adults. Arq Bras Cardiol 78: 382-387.
5. Lee-Chen GJ, Lin SP, Tang YF, et al (1999) Mucopolysaccharidosis type I: characterization of novel mutations affecting alpha- L -iduronidase activity. Clin Genet 56: 66-70.
6. Lee-Cheidentification and characterization of mutations affecting α- L -iduronidase activity. J Formos Med Assoc 101: 425-428.
7. Neufeld EF, Muenzer J (2001) The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 3421-3452.
8. Shih SL, Lee YJ, Lin SP, et al (2002) Airway changes in children with mucopolysaccharidoses. Acta Radiol 43: 40-43.
9. Wraith JE (2005) The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I. Expert Opin Pharmacother 6: 489-506.
10. Wraith JE, Clarke LA, Beck M, et al. (2004) Enzyme replacement therapy for mucopolysaccharidosis I: A randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase). J Pediatr 144: 581-588.